This study develops size-encoded molecular probes for simultaneous electro-optical nanopore sensing of microRNAs (miRNAs), enabling ultrasensitive, sequence-specific, and multiplexed detection directly in unprocessed human serum. The approach achieves femtomolar sensitivity and single-base mismatch selectivity, successfully monitoring miR-141-3p and miR-375-3p in prostate cancer patients with active disease and in remission. This technology offers a promising minimally invasive diagnostic tool for cancer.
Publisher
Nature Communications
Published On
Jun 10, 2021
Authors
Shenglin Cai, Thomas Pataillot-Meakin, Akifumi Shibakawa, Ren Ren, Charlotte L. Bevan, Sylvain Ladame, Aleksandar P. Ivanov, Joshua B. Edel
Tags
microRNAs
nanopore sensing
cancer diagnostics
ultrasensitive detection
prostate cancer
Related Publications
Explore these studies to deepen your understanding of the subject.